High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer.

Chen, Hanxiang; Zhao, Xia; Li, Yongqing; Zhang, Shaoming; Wang, Yunshan; Wang, Lili; Ma, Wanshan

Chen, Hanxiang; Zhao, Xia; Li, Yongqing; Zhang, Shaoming; Wang, Yunshan; Wang, Lili; Ma, Wanshan.

Afiliação

Chen H; Department of Clinical Laboratory, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.
Zhao X; Shandong LaiBo Biotechnology Co., Ltd., Jinan, China.
Li Y; Department of Clinical Laboratory, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.
Zhang S; Department of Clinical Laboratory, Shandong Provincial Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Wang Y; Shandong LaiBo Biotechnology Co., Ltd., Jinan, China.
Wang L; Medical Research and Laboratory Diagnostic Center, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Ma W; Department of Clinical Laboratory, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.

Front Genet ; 13: 908807, 2022.

Article em En | MEDLINE | ID: mdl-35832191

Palavras-chave

CESC; TMEM33; cell proliferation; immune infiltration; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google